Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

Related Parents

Related Issuers

IPT: Almirall E250m 5.5NC2 sr notes low 4s, pxg tomorrow

HYC European Market: Deal Flow - General

Almirall SA (ALMSM) EUR250m Reg S only sr notes due 2031 (5.5y). NC2 (50%,25%,par). (Expect Ba2)/BB+ (stable/stable). Via BNP/JPM (B&D) jt glocos and physical books/BBVA/BofA/Caixa/Santander jt books. List Lux. NY law. Denoms:100kx1k.

IPT: low 4s.

Roadshow (small group meetings) 12/02-03 (investor call 11am UKT 12/02). Pricing 12/03. UOP: along with EUR55m cash on hand, to redeem its EUR300m 2.125% sr notes due 09/30/26 (callable at 100). Biz: a publicly listed pharmaceutical company that researches, develops, produces and markets a fairly diversified portfolio of in-house developed drugs and in-licensed drugs in therapeutic areas including dermatology, respiratory, gastrointestinal and pain relief. HQ: Barcelona, Spain.

Netroadshow direct link: https://www.netroadshow.com/nrs/home/#!/?show=a364261a. Entry code: HEALTH25.

We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.